Latest news
Loading news…
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
Emergence Therapeutics was acquired by Eli Lilly in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Duisburg, Nordrhein-Westfalen, Germany
Key People at Emergence Therapeutics
Chief Medical Officer
1
professional contacts at Emergence Therapeutics
Contact execs at Emergence Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Emergence Therapeutics
Loading news…
FAQs about Emergence Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.